Antibody response to respiratory syncytial virus infection in children <18 months old

The development of a safe and effective respiratory syncytial virus (RSV) vaccine might be facilitated by knowledge of the natural immune response to this virus. The aims of this study were to evaluate the neutralizing antibody response of a cohort of healthy children <18 months old to RSV infect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Vaccin Immunother
Main Authors: Esposito, Susanna, Scarselli, Elisa, Lelii, Mara, Scala, Alessia, Vitelli, Alessandra, Capone, Stefania, Fornili, Marco, Biganzoli, Elia, Orenti, Annalisa, Nicosia, Alfredo, Cortese, Riccardo, Principi, Nicola
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964805/
https://ncbi.nlm.nih.gov/pubmed/26901128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1145847
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados